Adocia SA (EPA: ADOC)
France
· Delayed Price · Currency is EUR 8.18
-0.15 (-1.80%)
Nov 21, 2024, 4:30 PM CET
Adocia Revenue
Adocia had revenue of 1.45M EUR in the half year ending June 30, 2024, a decrease of -86.13%. This brings the company's revenue in the last twelve months to 3.59M, down -66.87% year-over-year. In the year 2023, Adocia had annual revenue of 6.05M, down -65.16%.
Revenue (ttm)
3.59M
Revenue Growth
-66.87%
P/S Ratio
31.71
Revenue / Employee
47.28K
Employees
78
Market Cap
126.92M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 6.05M | -11.31M | -65.16% |
| Dec 31, 2022 | 17.36M | 11.31M | 186.72% |
| Dec 31, 2021 | 6.06M | -778.00K | -11.39% |
| Dec 31, 2020 | 6.83M | -1.30M | -16.00% |
| Dec 31, 2019 | 8.14M | -45.80M | -84.92% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 48.45B |
| EssilorLuxottica Société anonyme | 25.83B |
| Sartorius Stedim Biotech S.A. | 2.74B |
| bioMérieux S.A. | 3.81B |
| Ipsen S.A. | 3.44B |
| Eurofins Scientific SE | 6.72B |
| Virbac SA | 1.34B |
| Ramsay Générale de Santé SA | 5.01B |